Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Daniel Q. Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Wesley K. Thompson, Davey M. Smith, Atul Malhotra, Ravindra L. Mehta, Vaishal Tolia, Jeffrey Yin, Paul A. Insel, Stone Leachman, Jinho Jung, Summer Collier, Lisa Richards, Kristin Woods, Maral Amangurbanova, Archana Bhatt, Xinlian ZhangOana M. Penciu, Stuart Zarich, Tamrat Retta, Michelle S. Harkins, J. Pedro Teixeira, Brian Chinnock, Netanya S. Utay, Jordan E. Lake, Rohit Loomba

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences